Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2018
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group
Emmanuel Meyer, David Pasquier, Guillemette Bernadou, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 26, 2019
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG
David Pasquier, Geoffrey Martinage, Guillaume Janoray, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2018
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group
Emmanuel Meyer, David Pasquier, Guillemette Bernadou, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 26, 2019
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG
David Pasquier, Geoffrey Martinage, Guillaume Janoray, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
Page
of 2